Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

Detalles Bibliográficos
Autores principales: Odeniyide, Patience, Yohe, Marielle E., Pollard, Kai, Vaseva, Angelina V., Calizo, Ana, Zhang, Lindy, Rodriguez, Fausto J., Gross, John M., Allen, Amy N., Wan, Xiaolin, Somwar, Romel, Schreck, Karisa C., Kessler, Linda, Wang, Jiawan, Pratilas, Christine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122821/
https://www.ncbi.nlm.nih.gov/pubmed/35534540
http://dx.doi.org/10.1038/s41388-022-02342-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122821/
https://www.ncbi.nlm.nih.gov/pubmed/35534540
http://dx.doi.org/10.1038/s41388-022-02342-6

Ejemplares similares